Akebia Therapeutics AKBA
NASDAQ AKBA
$0.86 -0.01 (-1.49%)
As of: Oct 2, 2026 · 1:06 PM EDT

Akebia Therapeutics (AKBA) Long-Term Investments (2015 - 2018)

Updated

Akebia Therapeutics' Long-Term Investments was $245,000 in Q4 2018.

Analysis

Akebia Therapeutics (AKBA) Long-Term Investments (2015 - 2018) Analysis & Trends

From Q1 2015 onward, Akebia Therapeutics has reported Long-Term Investments for 5 quarters.

  • Long-Term Investments shows a three-year compound annual growth rate of -83.0% (FY2015 to FY2018).
  • In earlier years, Long-Term Investments was $49.6 million in FY2015.
  • The Q4 2018 figure marks the highest quarterly Long-Term Investments since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 266.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.22 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 69.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 2.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.56 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.79 Bn
10 Akebia Therapeutics 250.00 Mn -419.48 Mn 38.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 245,000.00
Dec 31, 2015 49.60 Mn
Sep 30, 2015 50.97 Mn
Jun 30, 2015 38.76 Mn
Mar 31, 2015 33.10 Mn
API Access

Akebia Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=AKBA&period=max&api_key=YOUR_API_KEY